News from Economic Times Markets
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Cryptocurrency
Crypto Assets
Investors
Stocks
Ethereum
Shares
Stock Market
Stock
Markets
Xrp
Price
Blockchain
Sec
Investment
Eth
Etf
Stablecoin
Trade
Earnings
Revenue
China
Coinbase
Solana
Index
Bse
Usd
Token
Nasdaq
Trade War
Wall Street
Ipo
Inflation
Economy
Profit
Digital Assets
Interest Rates
Nvidia
Gold
Binance
Sp 500
Sensex
Trade Deal
Federal Reserve
Sales
Investor
Streaming
India Trade Deal
Fomc Meeting
Jersey Patch
Drug Market
Debt Management
Realty Firm
Consulting Firm
Moonchain
Real Estate Platform
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Economic Times Markets headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Economic Times Markets • May 27, 2025
Aurobindo Pharma shares jump 2% even as Q4 profit dips marginally to Rs 903 cr
Aurobindo Pharma experienced a slight decrease in quarterly profit despite increased revenue and overall annual earnings growth, driven by strong sales volumes and improved results...
Read Full Article →
Economic Times Markets • May 26, 2025
Aurobindo Pharma Q4 net dips marginally to Rs 903 cr; revenue at Rs 8,382 cr
Aurobindo Pharma’s consolidated profit after tax slightly decreased to Rs 903 crore in the fourth quarter ended March 2025, while its total revenue reached Rs 8,382 crore during th...
Read Full Article →